MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 75 filers reported holding MARINUS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $265,000 | +147.7% | 104,300 | +97.2% | 0.00% | – |
| Q1 2020 | $107,000 | +98.1% | 52,900 | +110.8% | 0.00% | – |
| Q4 2019 | $54,000 | +38.5% | 25,100 | 0.0% | 0.00% | – |
| Q3 2019 | $39,000 | -62.5% | 25,100 | 0.0% | 0.00% | – |
| Q2 2019 | $104,000 | +55.2% | 25,100 | +55.9% | 0.00% | – |
| Q1 2019 | $67,000 | -17.3% | 16,100 | -42.9% | 0.00% | – |
| Q4 2018 | $81,000 | -71.3% | 28,200 | 0.0% | 0.00% | – |
| Q3 2018 | $282,000 | +91.8% | 28,200 | +35.6% | 0.00% | – |
| Q2 2018 | $147,000 | – | 20,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 6,502,840 | $13,201,000 | 3.58% |
| Lion Point Capital, LP | 6,374,740 | $12,940,000 | 3.42% |
| Granite Point Capital Management, L.P. | 1,889,100 | $3,835,000 | 2.17% |
| Bain Capital Life Sciences Investors, LLC | 5,942,735 | $12,064,000 | 2.04% |
| Asymmetry Capital Management, L.P. | 855,318 | $1,736,000 | 1.90% |
| ACUTA CAPITAL PARTNERS, LLC | 1,038,000 | $2,107,000 | 1.02% |
| Bleichroeder LP | 1,250,000 | $2,538,000 | 0.66% |
| Boxer Capital, LLC | 4,800,000 | $9,744,000 | 0.66% |
| Avoro Capital Advisors LLC | 6,200,000 | $12,586,000 | 0.42% |
| Islet Management, LP | 1,000,000 | $2,030,000 | 0.30% |